Nurix therapeutics to present at upcoming investor conferences

San francisco, nov. 09, 2020 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), a biopharmaceutical company developing targeted protein modulation drugs, today announced that it will be presenting at the following healthcare investor conferences:

NRIX Ratings Summary

NRIX Quant Ranking